ELIXIR MYEXO product carton
MYEXO

AUTOLOGOUS EXOSOMES

Autologous exosomes for orthopaedics & sports medicine — tendons, ligaments, muscles and joints.

Autologous exosomes for orthopaedics & sports medicine — tendons, ligaments, muscles and joints.

Physician controlledExosome-rich plasmaPatient-derived & safeClosed systemCE certified · ISO 13485:2016

النسخة العربية ←

12TExosomes in 10 mL
30 minClosed-system preparation
≥89%Recovery
120 nmAverage exosome size (±15)
MyExo for orthopaedics

Autologous exosomes for musculoskeletal medicine

Beyond aesthetics, autologous exosome-rich plasma is applied in musculoskeletal and orthopaedic medicine. Exosomes promote chondrocyte metabolism, reduce synovial inflammation and accelerate tendon remodelling, improving functional recovery.

orthopedics
Tendons

Tendinopathies

Supports tendon remodelling and functional recovery.

Muscle

Muscle Tears

Supports organised, vascularised tissue repair.

Ligaments

Ligament Injuries

A biological approach to soft-tissue repair.

Joints

Early Osteoarthritis

Promotes chondrocyte metabolism and reduces synovial inflammation.

Mechanism

How exosomes act in musculoskeletal tissue

01

Inflammation Resolution

Exosomes suppress pro-inflammatory cytokines (IL-1β, TNF-α) and increase anti-inflammatory mediators (IL-10, TGF-β), accelerating the transition from inflammation to remodelling.

02

Structural Remodelling

Fibrin, exosomes and growth factors form a temporary three-dimensional scaffold for cell migration and matrix organisation.

03

Pain & Inflammation

By acting on inflammatory mediators and promoting repair, autologous exosomes are positioned as a biological approach in osteoarthritis, tendinopathies and chronic soft-tissue injuries.

What the research says

Exosome size and knee osteoarthritis outcomes

A 2025 study from the University of Iowa (Orthopaedic Journal of Sports Medicine) followed 58 patients with mild-to-moderate knee osteoarthritis after a single ultrasound-guided PRP injection and analysed the exosomes in each patient's PRP.

73%achieved ≥20% knee-pain reduction at 12 weeks
58patients, Kellgren-Lawrence grades 1–3

Response was linked to exosome size rather than platelet count or raw exosome concentration, and PRP exosomes were taken up by human cartilage cells in the laboratory. This study used conventional PRP, not MyExo; its message is that the character of the exosomes, which depends on preparation, matters.

Song I, Glass NA, et al. The Effect of Exosome Size in Platelet-Rich Plasma on Outcomes in Patients Treated for Knee Osteoarthritis. Orthop J Sports Med. 2025;13(9). doi:10.1177/23259671251360410

MyExo at a glance

Why autologous matters

12 trillionexosomes in 10 mL of final product
30 minfrom blood draw to exosome-rich plasma
Donor-free

From the Patient's Own Blood

Donor-free, with no additives.

Fresh

Prepared at the Point of Care

Physician-prepared, fresh, in the clinic.

Human EVs

Not a Cosmetic "Exosome"

Unlike cosmetic or plant-derived "exosome" products, which are typically topical and not interchangeable with human extracellular vesicles.

For healthcare professionals. Product information provided by the manufacturer. Distributed by Bionics Medical in the UAE and Saudi Arabia.

Scroll to Top